Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms

Abdominal Aortic Aneurysm Clinical Trial

Official title:

Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01850732
• Other study ID #: AAA-03
• Status: Completed
• Phase: N/A
• First received: May 7, 2013
• Last updated: June 25, 2014
• Start date: May 2013

Study information

• Verified date: June 2014
• Source: North Karelia Central Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Finland: Ethics CommitteeFinland: Valvira - National Supervisory Authority for Welfare and Health
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with transient ischemic attack (TIA) symptoms. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these TIA patients, thus making screening of these patients (for AAA) more cost-efficient.

Study will be carried out as a prospective screening study. Data will be collected in North Karelia Central Hospital within one year. All male patients with TIA symptoms will be recruited for the study and screened for AAA with ultrasound.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. primary completion date: June 2014
• Gender: Male
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• male patient who has had symptoms of transient ischemic attack (TIA)

Exclusion Criteria:

• Patient's denial to participate

• Female gender

• Already diagnosed or treated abdominal aortic aneurysm

Study Design

Primary Purpose: Screening

Related Conditions & MeSH terms

• Abdominal Aortic Aneurysm
• Aneurysm
• Aortic Aneurysm
• Aortic Aneurysm, Abdominal

Intervention

Other:
• Ultrasound of aorta

Locations

Country	Name	City	State
Finland	North Carelia Central Hospital	Joensuu	Pohjois-Karjala

Sponsors (1)

Lead Sponsor	Collaborator
North Karelia Central Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound		upon screening (collection of data will take one year)